See more : WisdomTree Crypto Altcoins (GB00BMTP1519.AS) Income Statement Analysis – Financial Results
Complete financial analysis of Hero Technologies Inc. (HENC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hero Technologies Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- CapitaLand Malaysia Trust (5180.KL) Income Statement Analysis – Financial Results
- Hapag-Lloyd Aktiengesellschaft (HPGLY) Income Statement Analysis – Financial Results
- CGrowth Capital, Inc. (CGRA) Income Statement Analysis – Financial Results
- Global SPAC Partners Co. (GLSPT) Income Statement Analysis – Financial Results
- Humatech, Inc. (HUMT) Income Statement Analysis – Financial Results
Hero Technologies Inc. (HENC)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://herotechnologiesinc.com
About Hero Technologies Inc.
Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recreational cannabis cultivation, production, distribution, packaging, and retail operations, as well as for dispensaries. The company was incorporated in 2004 and is headquartered in Dover, Delaware.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 1.53K | 197.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 495.78K | 40.09K | 0.00 | 0.00 | 0.00 | 58.96K | 0.00 | 0.00 |
| Cost of Revenue | 1.98K | 72.69K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -1.98K | -71.16K | 197.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.64M | 0.00 | 0.00 | 495.78K | 40.09K | 0.00 | 0.00 | 0.00 | 58.96K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | -4,666.30% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 505.00K | 1.17M | 5.78M | 74.37K | 0.00 | 0.00 | 228.09K | 441.79K | 345.99K | 415.71K | 997.52K | 555.89K | 1.84M | 2.14M | 167.03K | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 620.00 | 0.00 | 0.00 | 117.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 881.73K | 0.00 | 0.00 | 0.00 |
| SG&A | 505.62K | 1.17M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 997.52K | 555.89K | 1.84M | 2.14M | 1.05M | 1.33M | 28.20K | 20.08K |
| Other Expenses | 0.00 | 2.05K | 0.00 | 0.00 | 0.00 | 0.00 | 229.40K | 0.00 | 0.00 | 0.00 | 3.40K | 6.81K | 625.73K | 0.00 | 0.00 | 47.42K | 0.00 | 0.00 |
| Operating Expenses | 505.62K | 1.17M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 1.00M | 562.70K | 2.47M | 2.14M | 1.05M | 1.38M | 28.20K | 20.08K |
| Cost & Expenses | 507.60K | 1.24M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 1.00M | 562.70K | 2.47M | 2.14M | 1.05M | 1.38M | 28.20K | 20.08K |
| Interest Income | 183.00 | 46.96 | 58.90 | 53.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.28K | 0.00 | 0.00 |
| Interest Expense | 60.41K | 46.96K | 58.90K | 53.75K | 52.35K | 52.86K | 50.38K | 8.20K | 6.10K | 44.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 132.38K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.98K | 2.05K | 5.78M | 87.82K | 161.14K | 52.52K | 225.38K | -1.23M | 345.99 | 746.67K | -298.79K | -40.09K | 0.00 | 8.75M | -898.26K | 47.42K | 0.00 | 0.00 |
| EBITDA | -505.43K | -3.46M | -180.53K | -12.78M | 18.01K | -79.25K | 1.32K | -1.68M | 35.78K | 330.96K | -603.63K | -602.79K | -2.47M | -8.65M | -1.91M | -673.00K | -1.37M | -20.08K |
| EBITDA Ratio | 0.00% | -226,757.77% | -2,932,689.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -282.02% | -1,503.44% | 0.00% | 0.00% | 0.00% | -1,814.01% | 0.00% | 0.00% |
| Operating Income | -507.60K | -3.46M | -5.78M | -118.05K | -146.09K | -133.68K | -228.09K | -441.79K | 41.87K | -415.71K | -1.10M | -562.70K | -2.47M | -2.14M | -1.01M | -1.47M | -28.20K | -20.08K |
| Operating Income Ratio | 0.00% | -226,892.07% | -2,932,689.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -221.75% | -1,403.44% | 0.00% | 0.00% | 0.00% | -2,495.52% | 0.00% | 0.00% |
| Total Other Income/Expenses | -60.23K | -2.27M | -180.53K | -12.75M | 111.76K | 1.57K | 175.01K | -1.24M | 0.00 | 702.02K | 0.00 | 0.00 | 0.00 | -8.75M | 1.00 | 564.12K | -1.43M | 0.00 |
| Income Before Tax | -567.83K | -3.51M | -5.96M | -12.87M | -34.34K | -132.11K | -53.08K | -1.68M | 35.78K | 286.31K | -603.63K | -522.60K | -2.47M | -10.89M | -282.52K | -1.51M | -28.20K | -20.08K |
| Income Before Tax Ratio | 0.00% | -230,357.31% | -3,024,328.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -121.75% | -1,303.44% | 0.00% | 0.00% | 0.00% | -2,557.36% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -2.26M | 58.90K | -87.81 | -161.14K | -52.52K | 37.68K | 37.92K | -288.06K | 828.58K | -98.49K | 522.60K | 0.00 | -2.24M | -1.09M | 1.51M | 28.20K | 20.08K |
| Net Income | -541.58K | -1.25M | -6.02M | -12.87M | -34.34K | -132.11K | -90.76K | -1.72M | 323.84K | -542.27K | -603.63K | -522.60K | -2.47M | -8.65M | 808.32K | -1.51M | -28.20K | -20.08K |
| Net Income Ratio | 0.00% | -81,849.38% | -3,054,224.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -121.75% | -1,303.44% | 0.00% | 0.00% | 0.00% | -2,557.36% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | -0.04 | -0.09 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 | -0.09 | 0.01 | -0.02 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.04 | -0.09 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 | -0.09 | 0.01 | -0.02 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 447.96M | 430.07M | 154.88M | 143.69M | 136.00M | 125.19M | 115.32M | 112.64M | 111.02M | 110.33M | 109.78M | 108.57M | 107.24M | 100.84M | 85.86M | 63.74M | 59.42M | 43.99M |
| Weighted Avg Shares Out (Dil) | 447.59M | 430.07M | 154.88M | 143.69M | 136.00M | 125.19M | 115.32M | 112.64M | 111.02M | 110.33M | 109.78M | 108.57M | 107.24M | 100.84M | 85.86M | 63.74M | 59.42M | 43.99M |
Stocks to Watch: Yes Bank, Bharti Airtel, Hero MotoCorp, Wipro, Godrej Consumer
Madhu Kapur has withdrawn petition from the Bombay High Court over the nomination of people to the board of Yes Bank.Hero MotoCorp's standalone net profit fell 15% YoY to ₹620.7 crore during the March quarter
Southeastern Health Care at Home Launches New Website and Logo to Reflect Its Commitment to Patients and Hero Caregivers!
Southeastern Health Care at Home is launching its new brand and website. Our new brand captures the caring and dedication of our hero caregivers.
Sensex Rallies 1,000 Points; Hero MotoCorp & HCL Technologies Surge Over 6%
Share markets in India are presently trading on a strong note tracking positive global cues. Benchmark indices extended rally buoyed by encouraging data from coronavirus drug trials in the US.
Overwatch Patch Update Adds New Hero 'Echo' Along with Tweaks to In-Game Maps
Echo is the 32nd Hero to be added in Overwatch.
Sensex Zooms 1,000 Points; Hero MotoCorp & Bajaj Auto Surge Over 9%
Share markets in India are presently trading on a strong note. Benchmark indices extended gains, amid hopes that the Centre may announce more measures to boost the economy.
Source: https://incomestatements.info
Category: Stock Reports